Target (CBDY) Other Operating Expenses (2013 - 2026)
Target (CBDY) reported Other Operating Expenses of $272021.0 for Q1 2026, down 31.79% year-over-year from $398777.0 in Q1 2025, and down 14.63% quarter-over-quarter from $318635.0 in Q4 2025.
Target (CBDY) Other Operating Expenses (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of Other Operating Expenses data on file, last reported at $272021.0 in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $272021.0, down 31.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 22.34% YoY), and the FY2025 annual result was $1.4 million, down 17.44% from the prior year.
- Other Operating Expenses declined to $272021.0 in Q1 2026 per CBDY's latest filing, from $318635.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $466013.0 in Q4 2024 and troughed at -$64967.4 in Q4 2022.
- A 5-year average of $316246.0 and a median of $363980.0 in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses tumbled 127.19% in 2022, then surged 815.81% in 2023.
- A 5-year view of Other Operating Expenses shows it stood at -$64967.4 in 2022, then surged by 815.81% to $465044.0 in 2023, then advanced by 0.21% to $466013.0 in 2024, then slumped by 31.63% to $318635.0 in 2025, then declined by 14.63% to $272021.0 in 2026.
- Business Quant data shows CBDY's Other Operating Expenses at $272021.0 in Q1 2026, $318635.0 in Q4 2025, and $292364.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Target | - | - | 191,787.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 272,021.00 |
| Dec 31, 2025 | 318,635.00 |
| Sep 30, 2025 | 292,364.00 |
| Jun 30, 2025 | 381,352.00 |
| Mar 31, 2025 | 398,777.00 |
| Dec 31, 2024 | 466,013.00 |
| Sep 30, 2024 | 399,260.00 |
| Jun 30, 2024 | 363,980.00 |
| Mar 31, 2024 | 455,627.00 |
| Dec 31, 2023 | 465,044.00 |
| Sep 30, 2023 | 410,700.00 |
| Jun 30, 2023 | 270,880.00 |
| Mar 31, 2023 | 128,026.00 |
| Dec 31, 2022 | -64,967.44 |
| Sep 30, 2022 | 58,117.00 |
| Jun 30, 2022 | 334,100.88 |
| Mar 31, 2022 | 426,251.98 |
| Dec 31, 2021 | 238,898.88 |
| Sep 30, 2021 | 196,250.08 |
| Jun 30, 2021 | 124,434.00 |